Taysha Gene Therapies Inc.
TSHA | NASDAQ
$5.16
+$0.12 (+2.38%)
Sep 22, 2026, 1:03 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -46.64M | -42.41M | -27.85M | -32.73M | -26.88M | -21.53M | -18.79M | -25.52M | -20.93M | -24.06M | 47.74M | -117.09M | -24.6M | -17.62M | -55.72M | -26.53M | -34.09M | -50.32M | -50.39M | -51.19M | -40.93M | -32.02M |
Depreciation & Amortization | 291K | 295K | 299K | 286K | 277K | 283K | 304K | 294K | 322K | 325K | 366K | 331K | 343K | 331K | 364K | 277K | 273K | 260K | 209K | 166K | 85K | 32K |
Stock-Based Compensation | 5.81M | 5.55M | 3.53M | 3.29M | 3.19M | 3.29M | 3.22M | 3.36M | 3.33M | 3.2M | 1.97M | 2.04M | 2.22M | 1.68M | 4.1M | 4.47M | 4.14M | 5.33M | 4.96M | 5.09M | 4.55M | 3.59M |
Other Working Capital | 214K | -5.94M | -4.95M | 5.98M | -772K | -5.48M | -1.1M | -2.1M | -2.67M | -3.68M | -3.62M | -4.18M | -2.56M | -5.36M | 32.1M | 1.79M | -7.87M | -508K | 3.53M | -1.12M | 12.77M | -1.01M |
Other Non-Cash Items | -4.66M | 344K | 4.37M | 965K | 1.01M | 488K | -442K | 6.14M | 52K | 442K | -57.41M | 3.07M | 4.06M | 428K | 38.03M | 614K | 530K | 1.75M | 2.94M | 1.51M | 194K | 5.5M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.93M | 101.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 4.77M | -4.65M | -7.07M | 4.03M | 2.23M | -4.56M | -2.6M | -5.88M | -4.28M | 298K | -4.85M | -7.37M | -796K | -5M | 27.51M | -7.64M | -4.21M | 2.04M | 2.03M | 12.5M | 13.28M | 863K |
Operating Cash Flow | -40.43M | -40.88M | -26.72M | -24.17M | -20.18M | -22.02M | -18.31M | -21.62M | -21.5M | -19.8M | -16.12M | -17.95M | -18.77M | -20.19M | 14.28M | -28.81M | -33.35M | -40.94M | -40.26M | -31.93M | -22.82M | -22.04M |
Capital Expenditures | 1K | -3.02M | -250K | -108K | -2K | -378K | 2K | -35K | -201K | -140K | -17K | -3.5M | 48K | -3.9M | -2.31M | -3.02M | -8.11M | -11.43M | -8.52M | -4M | -8.5M | -534K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -3M | 3K | 60K | 64K | 7K | 11K | n/a | n/a | n/a | 7K | 10K | n/a | n/a | -61K | -1M | -250K | -3M | -250K | -500K | -5.5M | n/a |
Investing Cash Flow | 1K | -3.02M | -247K | -48K | 62K | -371K | 13K | -35K | -201K | -140K | -10K | -3.49M | 48K | -3.9M | -2.37M | -3.02M | -8.11M | -11.43M | -8.52M | -4M | -8.5M | -534K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.98M | 29.98M | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | -173K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 75K | 19K | -57K | 8.97M | 118K | -127K | 3K | -64K | -13K | -22K | 24K | -79K | 377K | -370K | 63K | -103K | 11.08M | -107K | -874K | n/a | n/a | n/a |
Financial Cash Flow | 216.66M | 711K | 49.56M | 8.8M | 216.29M | -52K | -357K | 6.6M | 70.47M | -22K | -4.25M | 140.63M | 377K | -370K | 41.67M | -103K | 11.08M | -107K | 9.11M | 29.98M | n/a | n/a |
Net Cash Flow | 176.23M | -43.19M | 22.59M | -15.42M | 196.17M | -22.44M | -18.65M | -15.06M | 48.76M | -19.96M | -20.38M | 119.2M | -18.34M | -24.46M | 53.57M | -31.93M | -30.39M | -52.47M | -39.67M | -5.96M | -31.31M | -22.57M |
Free Cash Flow | -40.42M | -43.9M | -26.97M | -24.27M | -20.18M | -22.4M | -18.31M | -21.65M | -21.71M | -19.94M | -16.13M | -21.45M | -18.72M | -24.09M | 11.97M | -31.83M | -41.47M | -52.37M | -48.78M | -35.94M | -31.31M | -22.57M |
Adj. Free Cash Flow | -46.23M | -49.45M | -30.5M | -27.56M | -23.37M | -25.69M | -21.52M | -25.01M | -25.04M | -23.14M | -18.1M | -23.49M | -20.94M | -25.76M | 7.87M | -36.3M | -45.61M | -57.7M | -53.73M | -41.02M | -35.86M | -26.16M |
Maintenance CapEx | -1K | -295K | n/a | -108K | n/a | -378K | 2K | -35K | -201K | -140K | n/a | n/a | 96K | n/a | n/a | -3.02M | -8.11M | -11.43M | -209K | -166K | -85K | -32K |
Growth CapEx | 2K | -2.73M | -250K | n/a | -2K | n/a | n/a | n/a | n/a | n/a | -17K | -3.5M | -48K | -3.9M | -2.31M | n/a | n/a | n/a | -8.31M | -3.84M | -8.41M | -502K |
Owner Earnings | -40.43M | -41.17M | -26.72M | -24.27M | -20.18M | -22.4M | -18.31M | -21.65M | -21.71M | -19.94M | -16.12M | -17.95M | -18.67M | -20.19M | 14.28M | -31.83M | -41.47M | -52.37M | -40.47M | -32.1M | -22.9M | -22.07M |
Add to Watchlist
Select watchlists to add or remove TSHA